Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $6,418 - $7,502
200 Added 2.64%
7,773 $255,000
Q2 2023

Aug 10, 2023

SELL
$36.12 - $41.79 $9,030 - $10,447
-250 Reduced 3.2%
7,573 $276,000
Q1 2023

May 09, 2023

BUY
$39.39 - $51.28 $61,960 - $80,663
1,573 Added 25.17%
7,823 $269,000
Q4 2022

Feb 08, 2023

SELL
$41.75 - $54.5 $71,058 - $92,759
-1,702 Reduced 21.4%
6,250 $320,000
Q2 2022

Jul 28, 2022

BUY
$46.53 - $55.17 $79,194 - $93,899
1,702 Added 27.23%
7,952 $414,000
Q2 2021

Aug 03, 2021

BUY
$35.91 - $40.68 $224,437 - $254,250
6,250 New
6,250 $206,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Lazard Freres Gestion S.A.S. Portfolio

Follow Lazard Freres Gestion S.A.S. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Freres Gestion S.A.S., based on Form 13F filings with the SEC.

News

Stay updated on Lazard Freres Gestion S.A.S. with notifications on news.